November 11, 2025 In Memoriam: C-Path Remembers Dr. Gil L’Italien’s Legacy of Science, Compassion, and Collaboration Critical Path Institute is deeply saddened by the passing of Dr. Gilbert L’Italien, or Gil to those who knew him...
November 3, 2025 Celebrating a Decade of Impact: Critical Path for Parkinson’s 10-Year Impact Report Now Available Critical Path for Parkinson’s (CPP), a global public-private partnership led by C-Path...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 7, 2025 C-Path CEO Romero Featured in Scientific American Feature The piece explores the concept of healthspan — the years of life lived free from serious disease — a topic gaining momentum...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 10, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 2 Recap Day 2 of the C-Path Global Impact Conference built on the momentum of opening day...
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million in 2025